Item 8.01 Other Events.

On June 6, 2022, Enochian Biosciences Inc. (the "Company") updated on its website its previously published letter to shareholders. A copy of the updated letter is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in this Item 8.01 and in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits





  (d) Exhibits:




EXHIBIT NO.     DESCRIPTION                         LOCATION
99.1              Shareholder Letter                Furnished herewith
104             Cover Page Interactive Data File
                (embedded within the Inline XBRL
                document)

© Edgar Online, source Glimpses